Astex - PDFSEARCH.IO - Document Search Engine

Astex
Results: 79

#	Item
31	October 2, 2012 Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Platinum-Resistant Recurrent Ovarian Cancer Patients DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (N Add to Reading List Source URL: astx.com Language: English Carboplatin Clinical trial Ovarian cancer Chemistry Alkylating antineoplastic agents Ammine complexes
32	June 22, 2012 Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasd Add to Reading List Source URL: astx.com Language: English Acute myeloid leukemia Myeloid leukemia Clinical research Design of experiments Myelodysplastic syndrome Astex Clinical trial Medicine Health Acute leukemia
33	SuperGen, Inc. Changes Name to Astex Pharmaceuticals, Inc., Announces New Stock Ticker Symbol and New Website DUBLIN, Calif.--(BUSINESS WIRE)-- SuperGen, Inc. (NASDAQ:ASTX) announced that it has officially begun operatin Add to Reading List Source URL: astx.com Language: English Astex Eisai
34	Astex Pharmaceuticals Reports 2011 Third Quarter Financial Results Completes Acquisition of Astex Therapeutics Limited Dacogen Royalty Revenue Increases 26% from Prior Year Ends Quarter with $128 Million in Cash & Market Add to Reading List Source URL: astx.com Language: English Business Deferral Net income Amortization Income tax in the United States Astex Expense Profit Depreciation Generally Accepted Accounting Principles Accountancy Finance
35	December 4, 2012 Astex Pharmaceuticals Announces December 14th Analyst and Investor Day Agenda DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicat Add to Reading List Source URL: astx.com Language: English
36	Astex Announces FDA ODAC Meeting of sNDA Application for Dacogen in Treatment of Elderly AML DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), today announced the pre-publication notice of the Add to Reading List Source URL: astx.com Language: English Syndromes Acute myeloid leukemia Leukemia Neutropenia Thrombocytopenia Decitabine Medicine Oncology Myelodysplastic syndrome
37	June 14, 2013 Astex Pharmaceuticals Announces Presentation of Updated Results of SGI[removed]Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology As Add to Reading List Source URL: astx.com Language: English Oncology Orphan drugs Myelodysplastic syndrome Syndromes Azacitidine Decitabine Cyclacel Medicine Nucleosides Triazines
38	Astex Pharmaceuticals Announces March 27th Analyst and Investor Day Agenda DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development Add to Reading List Source URL: astx.com Language: English
39	Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery an Add to Reading List Source URL: astx.com Language: English Indoles Organofluorides Pfizer Pyrroles Sunitinib Lactams Gastrointestinal stromal tumor Hsp90 Imatinib Chemistry Organic chemistry Medicine
40	July 8, 2013 Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator Investigational New Drug (IND) Application and Data Presentations Planned for the Fourth Quarter DUBLIN, Add to Reading List Source URL: astx.com Language: English Clinical research Pharmaceutical industry Food and Drug Administration Astex Eisai Decitabine Hypomethylating agent Clinical trial Drug discovery Pharmaceutical sciences Pharmacology Medicine

UPDATE